MAGELLAN LONGEVITY
HomeResearchStudy library › Fisetin is a senotherapeutic that extends health and lifespan
Study summary · Senescence, senolytics & the hallmarks of aging

Can flavonoids be identified that have more potent senolytic activity than previously known combinations, and can these extend health and lifespan?

In one paragraph

Fisetin Senolytic Capsules, an animal study (EBioMedicine 2018, PMID 30279143) — intervention with fisetin late in life was sufficient to provide significant health benefits, suggesting its potential for translation into human clinical studies. No numeric effect size is reported for Fisetin Senolytic Capsules in the source abstract.

Source: EBioMedicine 2018, PMID 30279143 ↗ · Research map · How Magellan grades evidence · evidence confidence: low

EBioMedicine · 2018 · PMID 30279143 · DOI 10.1016/j.ebiom.2018.09.015

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Fisetin, a natural flavonoid, acts as a potent senolytic in mice and human tissues, reducing age-related pathology and extending lifespan when administered late in life.

The question

Can flavonoids be identified that have more potent senolytic activity than previously known combinations, and can these extend health and lifespan?

What they tested

The researchers hypothesized that certain flavonoid polyphenols would exhibit potent senolytic activity, potentially surpassing existing treatments, and that this activity could translate into improved health and extended lifespan in animal models.

How they did it

A panel of 10 flavonoid polyphenols was screened for senolytic activity using senescent murine and human fibroblasts. The most potent flavonoid, fisetin, was then tested in mice modeling a progeroid syndrome and in aged wild-type mice to assess its effects on senescence markers, age-related histopathology, disease markers, health span, and lifespan. Human adipose tissue explants were also used to evaluate the translatability of the results.

What they found

Fisetin was identified as the most potent senolytic among the 10 flavonoids tested. Acute or intermittent treatment with fisetin reduced senescence markers in multiple tissues in progeroid and old mice, indicating a 'hit-and-run' senolytic mechanism. Fisetin also reduced senescence in specific cell types within murine and human adipose tissue. In wild-type mice, late-life administration of fisetin restored tissue homeostasis, reduced age-related pathology, and extended both median and maximum lifespan.

What it means

The natural product fisetin possesses senotherapeutic activity in mice and human tissues. Intervention with fisetin late in life was sufficient to provide significant health benefits, suggesting its potential for translation into human clinical studies.

Limitations

The study primarily used mouse models and human tissue explants, which may not fully reflect the complexity of human aging and disease. The specific mechanisms of fisetin's cell-type specificity were not fully elucidated.

“fisetin was the most potent senolytic”— from the published abstract, EBioMedicine 2018

The paper at a glance

TitleFisetin is a senotherapeutic that extends health and lifespan.
JournalEBioMedicine
Year2018
PMID30279143 ↗
DOI10.1016/j.ebiom.2018.09.015 ↗
TopicSenescence, senolytics & the hallmarks of aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Fisetin Senolytic Capsules

Because senescent cells accumulate with age and contribute to frailty, vascular dysfunction, inflammation, and multiple age-related diseases, selectively clearing them is a leading longevity strategy.

All-in-One Longevity Formulation

Several of NOVOS Core's ingredients have genuine, though mostly early-stage, human or animal evidence relevant to aging: trials of GlyNAC (glycine plus N-acetylcysteine) improved oxidative stress, mitochondrial function, strength and walking performance in older adults — though at glycine doses far above what the…

NOVOS Core All-In-One Sachets

NOVOS Core is a multi-ingredient dietary supplement marketed for longevity that combines about a dozen…

Check price on Amazon ↗

Fisetin Senolytic Capsules

Fisetin is a naturally occurring flavonol (a plant polyphenol) found in strawberries, apples…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Can flavonoids be identified that have more potent senolytic activity than previously known combinations, and can these extend health and lifespan? [Plain-English summary of EBioMedicine 2018, PMID 30279143, DOI 10.1016/j.ebiom.2018.09.015]. Magellan Longevity. https://magellanlongevity.com/study/s101.html
BibTeX
@misc{magellan_s101, title = {Can flavonoids be identified that have more potent senolytic activity than previously known combinations, and can these extend health and lifespan?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s101.html}}, note = {Plain-English summary of PubMed PMID 30279143; DOI 10.1016/j.ebiom.2018.09.015; EBioMedicine 2018. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s101.html

Related studies in the Magellan library

All 8 Magellan summaries on senescence, senolytics & the hallmarks of aging →

How this summary was made. Every section above restates what the published abstract of PMID 30279143 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.